Intake of anthocyanins and gastric cancer risk: A comprehensive meta-analysis on cohort and case-control studies

Abstract

This meta-analysis aimed to explore the association between anthocyanins intake and the risk of gastric cancer. All the relative articles have been searched in the online databases, including PubMed, EMBASE, Web of Science, and the Cochrane Library until June 11th, 2018. Risk ratios (RRs) or odds ratio (ORs) and their 95% confidence intervals were calculated and pooled through the STATA 12.0. A total of 6 studies were finally selected in the meta-analysis. No significant association was found between total anthocyanins consumption and gastric cancer risk (RR50.92, 95%CI: 0.81–1.04). Likewise, there was also no significant evidence of the relationship between anthocyanins intake and gastric cancer in tumor site (cardia: RR50.90, 95%CI: 0.62–1.31; noncardia: RR50.86, 95%CI: 0.69–1.07) and gender (men: RR51.02, 95%CI: 0.73–1.40; women: RR50.80, 95%CI: 0.52–1.23). The dose-response relationship was also not found in this meta-analysis. The Grades of Recommendations Assessment, Development and Evaluation (GRADE) quality in our study was very low. The results of our meta-analysis suggested the intake of anthocyanins had no association with the risk of gastric cancer and further studies are needed.